NO20021001L - Radiopharmaceutical products and processes for their preparation - Google Patents

Radiopharmaceutical products and processes for their preparation

Info

Publication number
NO20021001L
NO20021001L NO20021001A NO20021001A NO20021001L NO 20021001 L NO20021001 L NO 20021001L NO 20021001 A NO20021001 A NO 20021001A NO 20021001 A NO20021001 A NO 20021001A NO 20021001 L NO20021001 L NO 20021001L
Authority
NO
Norway
Prior art keywords
products
processes
preparation
radiopharmaceutical products
radiopharmaceutical
Prior art date
Application number
NO20021001A
Other languages
Norwegian (no)
Other versions
NO20021001D0 (en
Inventor
Emmanuel Bellande
Pierre Jallet
Benoit Denizot
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20021001D0 publication Critical patent/NO20021001D0/en
Publication of NO20021001L publication Critical patent/NO20021001L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Den foreliggende oppfinnelse angår radio-farmasøytiske produkter og fremgangsmåter for fremstilling derav. Disse produktene kan anvendes i lungescintigrafi eller i terapi. De omfatter et poly-sakkarid og sekvestreirngsgrupper med formlene R-NH-, R-N= og formel (I), hvori R er en hydro-karbon- eller aromatisk gruppe omfattende i det minste ett svovelatom, og R' er et hydrogenatom eller en alkylgruppe, slik som metyl, hvor nevnte sekvest-reringsgruppe danner et chelattypekompleks med et radioaktivt metall, slik som technetium.The present invention relates to radiopharmaceutical products and methods for their manufacture. These products can be used in pulmonary scintigraphy or in therapy. They comprise a polysaccharide and sequestration groups of the formulas R-NH-, RN = and formula (I), wherein R is a hydrocarbon or aromatic group comprising at least one sulfur atom, and R 'is a hydrogen atom or an alkyl group , such as methyl, wherein said sequestering group forms a chelate-type complex with a radioactive metal, such as technetium.

NO20021001A 1999-09-01 2002-02-28 Radiopharmaceutical products and processes for their preparation NO20021001L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910970A FR2797769B1 (en) 1999-09-01 1999-09-01 RADIOPHARMACEUTICAL PRODUCTS AND THEIR PREPARATION PROCESS
PCT/IB2000/001161 WO2001015746A1 (en) 1999-09-01 2000-08-23 Radiopharmaceutical products and their preparation procedure

Publications (2)

Publication Number Publication Date
NO20021001D0 NO20021001D0 (en) 2002-02-28
NO20021001L true NO20021001L (en) 2002-04-11

Family

ID=9549465

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021001A NO20021001L (en) 1999-09-01 2002-02-28 Radiopharmaceutical products and processes for their preparation

Country Status (23)

Country Link
EP (1) EP1210127A1 (en)
JP (1) JP2003508455A (en)
KR (1) KR20020040799A (en)
CN (1) CN1371292A (en)
AU (1) AU6463100A (en)
BG (1) BG106438A (en)
BR (1) BR0013729A (en)
CA (1) CA2383517A1 (en)
CZ (1) CZ2002782A3 (en)
EA (1) EA200200307A1 (en)
EE (1) EE200200105A (en)
FR (1) FR2797769B1 (en)
HK (1) HK1044893A1 (en)
HU (1) HUP0202714A2 (en)
IL (1) IL148076A0 (en)
MX (1) MXPA02001923A (en)
NO (1) NO20021001L (en)
NZ (1) NZ517377A (en)
PL (1) PL353803A1 (en)
SK (1) SK2772002A3 (en)
WO (1) WO2001015746A1 (en)
YU (1) YU14202A (en)
ZA (1) ZA200201057B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
FR2919189A1 (en) * 2007-07-26 2009-01-30 Cyclopharma Sa Lab NOVEL COMPOSITIONS BASED ON POLYOSIDES GRAFTED BY POLYAMINE OR POLYSOUFRE COMPOUNDS.
CN102977174B (en) * 2012-12-19 2015-04-22 北京师范大学 99mTc(CO)3 nuclear-labeled macrocyclic polyamine triazole ring glucose-based complex as well as preparation and application of complex
PL240772B1 (en) 2018-06-11 2022-06-06 Nanothea Spolka Akcyjna Method of producing polymer nanoparticles chelating radioactive isotopes for use in diagnostics and treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7412164L (en) * 1974-09-27 1976-03-29 Pharmacia Ab FUNDS FOR INTRAVASCULAR ADMINISTRATION
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
JPH08501097A (en) * 1992-09-04 1996-02-06 ザ ゼネラル ホスピタル コーポレーション Biocompatible polymers including clinical diagnostic and therapeutic moieties
US5958372A (en) * 1994-06-28 1999-09-28 Nycomed Imaging As Low viscosity chelating polymers for diagnostic imaging
FR2736834B1 (en) * 1995-07-17 1997-08-29 Cis Bio Int RADIOPHARMACEUTICAL PRODUCTS WITH CARDIAC TROPISM COMPRISING A NITRURO COMPLEX OF A TRANSITIONAL METAL AND HAVING FAST MYOCARDIAL CLEARANCE

Also Published As

Publication number Publication date
FR2797769A1 (en) 2001-03-02
JP2003508455A (en) 2003-03-04
ZA200201057B (en) 2003-07-30
EA200200307A1 (en) 2002-08-29
HUP0202714A2 (en) 2002-12-28
EE200200105A (en) 2003-04-15
MXPA02001923A (en) 2003-07-21
BG106438A (en) 2002-09-30
NZ517377A (en) 2003-08-29
CA2383517A1 (en) 2001-03-08
AU6463100A (en) 2001-03-26
EP1210127A1 (en) 2002-06-05
IL148076A0 (en) 2002-09-12
WO2001015746A1 (en) 2001-03-08
NO20021001D0 (en) 2002-02-28
CN1371292A (en) 2002-09-25
YU14202A (en) 2004-09-03
HK1044893A1 (en) 2002-11-08
PL353803A1 (en) 2003-12-01
FR2797769B1 (en) 2003-07-25
BR0013729A (en) 2002-05-07
KR20020040799A (en) 2002-05-30
CZ2002782A3 (en) 2002-08-14
SK2772002A3 (en) 2002-09-10

Similar Documents

Publication Publication Date Title
NO20021001L (en) Radiopharmaceutical products and processes for their preparation
MY105402A (en) 17-beta-substituted-4-aza-5alpha-androstan-3-one derivatives and process for their preparation.
RS49906B (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
DE3853415T2 (en) Macrocyclic chelating agents and chelates made therefrom.
NO812355L (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3,1-BENZOKSAZIN-2-ON DERIVATIVES
DK55584D0 (en) UNKNOWN CARBACYCLINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS A MEDICINE
CO4980887A1 (en) NEW 3,4-DIARILTIAZOLINA-2-UNO OR 2-TIONO DERIVATIVES, THEIR PREPARATION METHODS AND THERAPEUTIC USE
HUP9801072A2 (en) Substituted 6- and 7-amino-tetrahydro-isoquinoline-carboxylic acid derivatives, pharmaceutical compositions containing them and process for producing them
DE60020885D1 (en) TETRAHYDROPYRIDINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE3164763D1 (en) Anthracycline glycosides, process for the preparation thereof, intermediate compounds and their preparation and pharmaceutical compositions
DK157489C (en) N-SUBSTITUTED PYRIDINIUM COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
ATE78032T1 (en) 2-PYRIDYLACETIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TR200003857T2 (en) New 19-nor steroids halogenated at 17.
DK0434560T3 (en) Newly substituted amino acid derivatives, processes for their preparation and pharmaceutical agents containing them
ES8201541A1 (en) Hypoglycemic guanylamidines, processes for their preparation, and pharmaceutical compositions containing them.
MY107827A (en) Isoquinolline compounds, compositions and use
ATE268775T1 (en) DIAZEPINECARBOXAMIDE DERIVATIVES, METHOD FOR THEIR PRODUCTION, THEIR USE AS MEDICINAL PRODUCTS, PHARMACEUTICAL PREPARATIONS AND THEIR USE
DK578785A (en) 9-HALOGEN PERFORMANCE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
ES410034A1 (en) Procedure for the preparation of 2- (tienil-3'-amino) -1, 3 - diazaciclopentenos- (2). (Machine-translation by Google Translate, not legally binding)
BR9912266B1 (en) compound derived from 6-deoxy erythromycin as well as medicaments and pharmaceutical compositions containing them.
ATE44741T1 (en) 2-(N-SUBSTITUTED GUANIDINO)-4HETEROARYLTHIAZOLE AS ANTI-ULCER AGENTS.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application